Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 5
1992 7
1993 10
1994 12
1995 14
1996 23
1997 12
1998 17
1999 18
2000 18
2001 25
2002 18
2003 19
2004 17
2005 15
2006 20
2007 26
2008 19
2009 31
2010 38
2011 37
2012 44
2013 44
2014 47
2015 68
2016 50
2017 59
2018 43
2019 67
2020 50
2021 57
2022 41
2023 43
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

934 results

Results by year

Filters applied: . Clear all
Page 1
Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A, Soma L. Shustov A, et al. Cancer Treat Res. 2019;176:127-144. doi: 10.1007/978-3-319-99716-2_6. Cancer Treat Res. 2019. PMID: 30596216 Review.
Anaplastic Large Cell Lymphomas (ALCL) are clinically aggressive and pathologically distinct lymphoid neoplasms that originate from a mature post-thymic T-cell. The contemporary World Health Organization (WHO) Classification of Haematologic Malignancie
Anaplastic Large Cell Lymphomas (ALCL) are clinically aggressive and pathologically distinct lymphoid neoplasms that or
Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Nolè F, Veronesi P, Curigliano G. Marra A, et al. Cancer Treat Rev. 2020 Mar;84:101963. doi: 10.1016/j.ctrv.2020.101963. Epub 2020 Jan 13. Cancer Treat Rev. 2020. PMID: 31958739 Review.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently recognized non-Hodgkin lymphoma of T-cell origin. ...For patients with advanced and disseminated diseases, the treatment did not differ from other types of …
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently recognized non-Hodgkin lymp
Cutaneous T-cell Lymphoma.
Pulitzer M. Pulitzer M. Clin Lab Med. 2017 Sep;37(3):527-546. doi: 10.1016/j.cll.2017.06.006. Clin Lab Med. 2017. PMID: 28802499 Free PMC article. Review.
Cutaneous T-cell lymphomas comprise a heterogeneous group of diseases characterized by monoclonal proliferations of T lymphocytes primarily involving skin, modified skin appendages, and some mucosal sites. ...Select unusual phenotypes or diagnostic examples of classic phen …
Cutaneous T-cell lymphomas comprise a heterogeneous group of diseases characterized by monoclonal proliferations of T lymphocytes pri …
Uncommon complications of breast prostheses.
Sánchez Rubio N, Lannegrand Menéndez B, Duque Muñoz M, Montes Fernández M, Ciudad Fernández MJ. Sánchez Rubio N, et al. Radiologia (Engl Ed). 2020 Jul-Aug;62(4):266-279. doi: 10.1016/j.rx.2020.01.008. Epub 2020 Apr 6. Radiologia (Engl Ed). 2020. PMID: 32273126 Free article. Review. English, Spanish.
However, the increasingly growing number of patients with breast implants has led to the increased likelihood of coming across less common complications; these include seromas or late infection; adenopathies in the internal mammary chain; granulomas in the capsule of the implant, …
However, the increasingly growing number of patients with breast implants has led to the increased likelihood of coming across less common c …
Extranodal T- and NK-cell lymphomas.
de Leval L, Feldman AL, Pileri S, Nakamura S, Gaulard P. de Leval L, et al. Virchows Arch. 2023 Jan;482(1):245-264. doi: 10.1007/s00428-022-03434-0. Epub 2022 Nov 7. Virchows Arch. 2023. PMID: 36336765 Free PMC article. Review.
Their nomenclature refers to their usual clinical presentation and predilection for specific anatomic sites-i.e. extranodal NK/T-cell lymphoma, nasal-type, hepatosplenic T-cell lymphoma, primary intestinal T-cell lymphomas, indolent lymphoprolif …
Their nomenclature refers to their usual clinical presentation and predilection for specific anatomic sites-i.e. extranodal NK/T-cell
Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman AL, Laurent C, Narbaitz M, Nakamura S, Chan WC, de Leval L, Gaulard P. Feldman AL, et al. Virchows Arch. 2023 Jan;482(1):265-279. doi: 10.1007/s00428-022-03412-6. Epub 2022 Oct 10. Virchows Arch. 2023. PMID: 36210383 Review.
Classification of anaplastic large cell lymphoma (ALCL) remains essentially unchanged; DUSP22-rearranged cases are now considered a genetic subtype of ALK-negative ALCL. Primary nodal EBV-positive T-/NK-cell lymphoma is introduced as a ne …
Classification of anaplastic large cell lymphoma (ALCL) remains essentially unchanged; DUSP22-rearranged cases a …
The role of the ALK receptor in cancer biology.
Hallberg B, Palmer RH. Hallberg B, et al. Ann Oncol. 2016 Sep;27 Suppl 3:iii4-iii15. doi: 10.1093/annonc/mdw301. Ann Oncol. 2016. PMID: 27573755 Free article. Review.
A vast array of oncogenic variants has been identified for anaplastic lymphoma kinase (ALK). Therefore, there is a need to better understand the role of ALK in cancer biology in order to optimise treatment strategies. ...A wide variety of ALK fusions, in which the k …
A vast array of oncogenic variants has been identified for anaplastic lymphoma kinase (ALK). Therefore, there is a need to bet …
Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Tsuyama N, et al. J Clin Exp Hematop. 2017;57(3):120-142. doi: 10.3960/jslrt.17023. J Clin Exp Hematop. 2017. PMID: 29279550 Free PMC article. Review.
Anaplastic large cell lymphoma (ALCL) was first described in 1985 as a large-cell neoplasm with anaplastic morphology immunostained by the Ki-1 antibody, which recognizes CD30. In 1994, the nucleophosmin (NPM)-anaplastic
Anaplastic large cell lymphoma (ALCL) was first described in 1985 as a large-cell neoplasm with
Anaplastic large cell lymphoma in paediatric and young adult patients.
Turner SD, Lamant L, Kenner L, Brugières L. Turner SD, et al. Br J Haematol. 2016 May;173(4):560-72. doi: 10.1111/bjh.13958. Epub 2016 Feb 23. Br J Haematol. 2016. PMID: 26913827 Free article. Review.
Anaplastic large cell lymphoma (ALCL) is a heterogeneous disease of debateable origin that, in children, is largely anaplastic lymphoma kinase (ALK) positive with aberrant ALK activity induced following the formation of chromosomal transl
Anaplastic large cell lymphoma (ALCL) is a heterogeneous disease of debateable origin that, in children, is larg
Pathology and genetics of anaplastic large cell lymphoma.
Leventaki V, Bhattacharyya S, Lim MS. Leventaki V, et al. Semin Diagn Pathol. 2020 Jan;37(1):57-71. doi: 10.1053/j.semdp.2019.12.002. Epub 2019 Dec 18. Semin Diagn Pathol. 2020. PMID: 31882178 Review.
Anaplastic large cell lymphomas are a rare subtype of peripheral/mature T-cell lymphomas which are clinically, pathologically and genetically heterogeneous. Both ALK-positive (ALK+) and ALK-negative (ALK-) ALCL are composed of large lymphoid cel
Anaplastic large cell lymphomas are a rare subtype of peripheral/mature T-cell lymphomas which are clinically, p
934 results